Objective: To evaluate the clinical characteristics and treatment outcomes of children with rhabdomyosarcoma diagnosed and treated at King Hussein Medical Center.
Introduction
Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue sarcoma, accounting for about 40% ( 
1,2)
Its annual incidence is 4.3 cases per million people younger than 20 years.
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Vol. 23 No. 3 Sep 2016 29 common neoplasm. (5) It originates from undifferentiated mesenchymal cells that can arise at any site in the body except in the bone and resembles morphology of developing skeletal muscle.
(6,7)
Overall survival (OS) rates for children with RMS have risen significantly due to the use of combined modality therapy trials including surgery, radiotherapy, and chemotherapy conducted by large international cooperative groups, such as the Intergroup Rhabdomyosarcoma Study Group IRSG( now known as the Soft Tissue Sarcoma Committee of the Children's Oncology Group). (8, 9) Histologically , embryonal and alveolar RMS are the two major subtypes, accounting for over 90 percent of cases in children under the age of five.
(10)
Other, minor, histologic variants include spindle cell, botryoid, and not otherwise specified( NOS).
(11-14)
Risk stratification for RMS used by the Children's Oncology Group (COG) is based on pretreatment TNM staging system based on tumor size, invasiveness, nodal status, primary site of primary tumor, and distant metastases. Overall survival(OS) was calculated from the date of diagnosis to death or to the date of follow-up loss .Event Free Survival (EFS) was calculated from the date of diagnosis to an event (relapse or death ) . Descriptive analysis using frequencies was used to describe the study variables.
Results
The total number of RMS patients diagnosed during the period from April 2005 to March 2012was 52. Their ages ranged between 0.25-13.75 years .The median age of our patients at diagnosis was 5 years .Forty two patients( 80.8%) were below the age of 10 years. The male to female ratio was 1.08 : 1. The demographic characteristics of the patients are summarized in Table I . Embryonal RMS was the most frequent histopathologic subtype (n = 47, 90.4%), while the alveolar histology was encountered in only 2 patients (3.8% ).Regarding the primary site of RMS , it was found to be highest in the head and neck (46.2%) followed by extremities ( 21.2%) . Table II and III. The 3-year event -free survival rate and the 3-year overall survival rate for patients according to the three risk groups was illustrated in Table IV . This is similar to a recent study done in the central region of Tunisia by Missaoui N et al. in 2010 who reported that almost two third of patients with RMS were diagnosed before 7 years of age. This also agrees with data from the IRS IV which reported that the median age of patients with RMS was 5-year, with 72% of patients below the age of 10 years. Our current study showed that RMS was slightly more predominant in males (51.9%) ,with male to female ratio 1.08 : 1. This ratio was lower than an earlier Jordanian study which was conducted over a 5 -year period between Jan 2004 and Dec 2008 , and showed that out of 45 patients , 31(69%) were males and 14(31%) were females. 22 Compared to our results , IRS IV also reported higher male to female ratio (1.6 : 1) .
(21)
The male to female ratio was even higher in three african studies from central region of Tunisia, Morocco and Egypt where it reached up to 2.7 , 2 and 1.75 respectively. Our study showed that Embryonal RMS was the most frequent pathologic subtype, accounting for 90.4% as showed in Table II The IRS IV reported that the embryonal subtype represents 70% including the botryoid and spindle cell variants, which is comparable to our results as the most frequent pathologic type . The present study showed that head and neck was the most common primary site of RMS (46.2%) followed by the extremities(21.2%). Our results were similar to that observed in Egypt,Tunisia,Morocco, Turkey ,Iran and Europe which showed that head and neck was the most frequent site of involvement by RMS. (2,3,19,20,23,25-27) . This is supported by the IRS IV , who reported that head and neck was the most commonly affected primary site of tumor (41%). On the other hand ,similar to our results, a more recent study from Egypt in 2012 found that the extremities ranks second after head and neck regarding the primary site of tumor. These differences may be explained by the variable number of patients included in these studies. The present study described the stages of RMS in pediatric age group, as seen in Table III . In which, the more advanced stages( stage III and IV) were unfortunately the predominant accounting for 36.5% and 28.8% respectively ,while the less advanced stages (stage I and II ) constituted 9.6% and 25.0% respectively. These results slightly differ from an earlier Jordanian 5 -year retrospective study of 45 children with RMS , which revealed that stage III was the most frequent stage (n= 22), followed by stage I (n=8), then stage II (n=8), and lastly stage IV (n=7). In our study, the relative frequencies of RMS groups showed that the majority of patients, were classified as post surgical group III and IV, constituting 42.3% and 28.8% respectively, as illustrated in Table III . . The high percentage of advanced stage and group of our patients at presentation may indicate the lack of awareness of families and primary health care physicians of the need for early medical advice of specialized centers for diagnosis and treatment . This can be also explained by the wide presenting symptoms and signs of this highly malignant and heterogeneous soft tissue tumor. This may indicate the need for health education for the general population to create awareness , and building up trained health professionals at all levels to promote early diagnosis. In the present study , the 3-year EFS ( 55.8 %) and OS (61.5 %) rates were slightly lower than the 4-year progression-free survival (61% ± 7.5%) and OS (72% ± 6.9%) rates reported by Al-Jumaily U et al from Jordan .
(22)
This can be explained by the higher percentage of stage IV ,post surgical group IV and high risk group (28.8 %) in our study compared to 15.6% in the earlier Jordanian study. several studies from Egypt and Japan showed EFS and OS rates close to our results. The IRS IV reported 3-year FFS and OS OF 77% and 86%, respectively. Moreover, in this study ,the 3-year FFS and OS was significantly lower in patients with high risk group (6.7% , 13.3% respectively) compared to low and intermediate risk groups as showed in Table IV , which is consistent with results reported previously about RMS. the European experience showed by the International Society of Paediatric Oncology (SIOP) is illustrated in the MMT( Malignant Mesenchymal Tumor ) 89 study, which included 503 patients and revealed that the Five-year overall survival (OS) and eventfree survival (EFS) rates were 71and 57, respectively.
(31)
There are some limitations of this study, which included the retrospective nature of the present work and being an experience of a single institution .Moreover, it included a relatively small number of subjects Future multi-institutional prospective clinical studies have to be carried out to study the epidemiology and clinical characteristics of this tumor at the level of the country.
Conclusion
Childhood Rhabdomyosarcoma in patients treated at KHMC showed unfortunately high frequencies of advanced stages( stage III and IV) , advanced postsurgical groups ( group III and IV) and then high risk groups , which significantly affected the clinical outcome and survival. Data describing the epidemiological features other than the gender distribution were close to the previously reported worldwide data.
